Hepion Pharmaceuticals
HEPA
#10576
Rank
A$0.62 M
Marketcap
A$0.05346
Share price
0.00%
Change (1 day)
-99.59%
Change (1 year)

Earnings for Hepion Pharmaceuticals (HEPA)

Earnings in 2025 (TTM): -A$7.39 Million

According to Hepion Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -A$22.38 Million, an increase over its 2023 earnings that were of -A$71.05 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hepion Pharmaceuticals from 2014 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$7.39 Million-66.98%
2024 -A$22.38 Million-68.5%
2023 -A$71.05 Million9.74%
2022 -A$64.75 Million37.49%
2021 -A$47.1 Million61.27%
2020 -A$29.21 Million174.55%
2019 -A$10.64 Million-31.28%
2018 -A$15.48 Million
2016 -A$30.72 Million6.03%
2015 -A$28.97 Million265%
2014 -A$7.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-A$0.22 Billion 3,034.96%๐Ÿ‡บ๐Ÿ‡ธ USA